Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Enanta Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

13 Feb 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Enanta Pharmaceuticals Inc (ENTA-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

12 Feb 2016 Thomson Reuters Stock Report 12 $25.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ENANTA PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

12 Feb 2016 Jefferson Research 11 $20.00

Enanta Pharmaceuticals

11 Feb 2016 S&P Capital IQ Factual Report 13 $150.00

Enanta Pharmaceuticals, Inc. (ENTA) - Financial Analysis Review

Enanta Pharmaceuticals, Inc. (ENTA) - Financial Analysis Review Summary Enanta Pharmaceuticals, Inc. (Enanta) is a biotechnol...

11 Feb 2016 GlobalData 36 $300.00

ValuEngine Rating and Forecast Report for ENTA

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

07 Feb 2016 ValuEngine, Inc. 11 $25.00

ENANTA PHARMACEUTICALS INC (ENTA=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

06 Feb 2016 Pechala's Reports 2 $25.00

Value Graph: ENANTA PHARMA -- ENTA

05 Feb 2016 Ford Investor Services, Inc. 1 $12.00

Wright Investors Service Comprehensive Report for Enanta Pharmaceuticals Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

30 Jan 2016 Wright Reports 54 $75.00

Validea Guru Analysis Report for ENTA. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.

Validea's Guru Stock Report uses an interpretation of the published stock-picking strategies developed by 10 investing legend...

29 Jan 2016 Validea 0 $12.00